Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants

Fig. 2

Intranasal delivery of adjuvanted RBDXBB.1.5-HR vaccine induces strong local mucosal immune response. The absolute number of CD8+ and CD4+ tissue-resident memory T (TRM) cells in (a) BALF and (b) lung samples from vaccinated mice. TRM cells were gated on CD44+CD62L-CD69+CD4+ or CD44+CD69+CD103+CD8+ (n = 5 mice each group). c The percentages of antigen specific IFN-γ or TNF-α-producing memory CD8+ and CD4+ T cells in lung tissue after stimulation with peptide pools for SARS-CoV-2 XBB.1.5 spike (n = 6 mice each group). d The frequencies of T follicular helper cells (CD4+PD-1+CXCR5+), germinal center B cells (CD19+GL7+CD95+), and RBD-specific B cells (RBD+CD19+) in mediastinal lymph nodes (n = 6 mice each group). The representative images and quantitative analysis of RBD-specific IgG (left) and IgA (right) antibody secreting cells (ASCs) in the (e) lung and (f) spleen tissues (n = 6 mice per group). The middle line indicates the median and the box shows the data range. P values were conducted by One-way ANOVA analysis followed by Tukey’s multiple comparisons test in a–f. ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05; ns not significant

Back to article page